Nu Skin Enterprises (NUS) Can't Be Bought Until China Bottoms, Canaccord Genuity Says
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/26/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
- Needham Starts NeoVolta (NEOV) at Buy
- TD Cowen: 'Sober View Suggests Structural Alcohol Risks Are Overblown'
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
Nu Skin Enterprises (NUS) Tops Q3 EPS by 19c; Issues Weak Q4 Outlook
November 5, 2014 7:32 AM ESTNu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $1.12, $0.19 better than the analyst estimate of $0.93. Revenue for the quarter came in at $638.8 million versus the consensus estimate of $628.83 million.
Regional Results
Greater China. In Greater China, third-quarter revenue declined 50 percent to $226.7 million when compared to the prior-year period, which included $153.6 million of limited-time offer (LTO) sales, compared to $59.3 million of LTO sales in the third quarter of 2014. The region's results were not impacted by foreign currency fluctuations. The sales leader count in the region declined 57 percent, while the number of actives... More
